A total of 76 participants from Jamaica, Zimbabwe, South Africa, Uganda, Malawi, Lesotho, Sudan, Panama and many other countries attended the IATT webinar on August 11 to learn about the use of PrEP (pre-exposure prophylaxis) during pregnancy.
The links to the presentations and webinar summary are below:
- Efficacy & Eligibility of HIV PrEP: Considerations for Pregnant Women
- Review: Safety of Tenofovir PrEP in Pregnant and Breastfeeding HIV-Uninfected Women and Their Infants
- Community Perspectives
- Webinar Summary